The Partnership Opportunities that Exist at the LSI USA Medtech Conference
In today’s healthcare industry, partnerships are vital to accelerate innovation, shorten the time to market for new commercialized medtech technologies, and drive global adoption. The LSI USA Medtech Conference (formerly known as LSI Emerging Medtech Summit) has evolved into one of the largest and most significant platforms in the world that catalyzes strategic partnerships and alliances. The LSI conference brings together medtech innovators, investors, and global healthcare leaders to create unique partnerships and alliances that shape the future of medical technology.
The Ecosystem for Partnership Development is Unique to the LSI USA Conference
The LSI USA Conference is structured to provide the appropriate means for developing strong relationships. The LSI USA Conference employs three distinct methods of interaction — presentations, one-on-one meetings, and networking forums — to enable attendees to build partnerships in the most effective and efficient manner possible. Companies attend the LSI USA conference to find:
- Strategic acquirers looking to expand their respective device portfolio
- Venture capital firms that are seeking high-potential technologies
- Distributors/channel partners that can assist with their market expansion efforts
- Collaborators in research and development to develop product or service co-development opportunities
Through this curated matchmaking process, building partnerships will be done in a more timely, efficient, and effective manner.
Contributing Factors to the Success of Partnerships Formed at the LSI Conference:
- High-Quality Medtech Deal Flow: Hundreds of innovative medtech companies have presented breakthrough technologies and products.
- Alignment Between Investors and Medtech Companies: Capital-providing investors will interact with founders to identify areas of common interest.
- A Global Gathering: Most of our attendees represent manufacturers and businesses from across the United States, Europe, and Asia.
- A Focus on Commercialization: All discussions at the LSI Summit will center on real-world commercialization opportunities.
Partnership Development Will be Facilitated by Each of the Above.
Through the Partnership Development at the LSI Medtech Conference, Innovative Medtech Startups Can Expedite Their Path to Market by:
- Reducing the time required to access U.S. and global markets
- Enhancing their commercialization and distribution strategies
- Establishing their credibility by securing strategic endorsements
- Providing potential pathways for licensing, co-development, or acquisition
As such, by Developing These Partnerships, Medtech Startups Can Significantly Reduce Their Path to Market From Prototype.
The LSI USA Medtech Conference, more than any other, facilitates medtech partnerships worldwide. By connecting innovators with investors, strategics, and global partners, the LSI Conference has a proven record of helping develop collaborations that will advance innovations in healthcare and result in the success of emerging medical technologies.